46 related articles for article (PubMed ID: 8725730)
1. An experimental model of intracranial hemorrhage during thrombolytic therapy with t-PA.
Paoni NF; Steinmetz HG; Gillett N; Refino CJ; Badillo JM; Bunting S
Thromb Haemost; 1996 May; 75(5):820-6. PubMed ID: 8725730
[TBL] [Abstract][Full Text] [Related]
2. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
3. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
[TBL] [Abstract][Full Text] [Related]
4. Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs.
Absher PM; Hendley E; Jaworski DM; Taatjes DJ; Sobel BE
Coron Artery Dis; 1999 Sep; 10(6):413-20. PubMed ID: 10474793
[TBL] [Abstract][Full Text] [Related]
5. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
[TBL] [Abstract][Full Text] [Related]
6. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
7. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
[TBL] [Abstract][Full Text] [Related]
8. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project.
Huynh T; Cox JL; Massel D; Davies C; Hilbe J; Warnica W; Daly PA;
Am Heart J; 2004 Jul; 148(1):86-91. PubMed ID: 15215796
[TBL] [Abstract][Full Text] [Related]
9. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
10. Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits.
Bowes MP; Zivin JA; Thomas GR; Thibodeaux H; Fagan SC
Exp Neurol; 1996 Sep; 141(1):40-6. PubMed ID: 8797666
[TBL] [Abstract][Full Text] [Related]
11. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
Ueshima S; Matsuno H; Hayashi M; Horibuchi K; Okada K; Fukao H; Uematsu T; Matsuo O
Thromb Haemost; 2002 Jun; 87(6):1069-74. PubMed ID: 12083488
[TBL] [Abstract][Full Text] [Related]
12. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
[TBL] [Abstract][Full Text] [Related]
13. Potential cost effectiveness of tissue plasminogen activator among patients previously treated with streptokinase.
Massel D
Can J Cardiol; 1999 Feb; 15(2):173-9. PubMed ID: 10079776
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years.
Zenz W; Arlt F; Sodia S; Berghold A
Semin Thromb Hemost; 1997; 23(3):321-32. PubMed ID: 9255912
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic therapy for acute myocardial infarction: what dose should be used?
Conti CR
Clin Cardiol; 2000 Sep; 23(9):635-6. PubMed ID: 11016011
[TBL] [Abstract][Full Text] [Related]
16. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
17. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
Asahi M; Asahi K; Wang X; Lo EH
J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
[TBL] [Abstract][Full Text] [Related]
18. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
19. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
20. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK
Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
